Eventide Asset Management »

Maze Therapeatics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $13M 324k 41.43

More positions owned by Eventide Asset Management

Guardant Health (GH)
Xometry Class A Com (XMTR)
Mirum Pharmaceuticals (MIRM)
Trane Technologies SHS (TT)
Beta Bionics (BBNX)
Irhythm Technologies (IRTC)
Ge Vernova (GEV)
Lam Research Corp Com New (LRCX)
Scholar Rock Hldg Corp (SRRK)
Axsome Therapeutics (AXSM)
Argenx Se Sponsored Adr (ARGX)
Old Dominion Freight Line (ODFL)
Targa Res Corp (TRGP)
Toast Cl A (TOST)
Collegium Pharmaceutical Inc Common Stock Usd (COLL)

View all positions for Eventide Asset Management

Top funds holding Maze Therapeatics

Frazier Life Sciences Management
Trv Gp Iv
Deep Track Capital
Arch Venture Corp
BlackRock
AH Capital Management
Vanguard Group
VR Adviser
Alphabet
General Catalyst Group Management
Woodline Partners
TRV GP V
Logos Global Management
Bellevue Group
Marshall Wace

View all funds holding Maze Therapeatics